Top Markets
Coin of the day
Handa Pharmaceuticals, Inc. Handa Pharmaceuticals, Inc.

Handa Pharmaceuticals, Inc.

6620
주식 순위 #13384
Handa Pharmaceuticals, Inc. operates as a specialized drug company,... Handa Pharmaceuticals, Inc. operates as a specialized drug company, concentrating its efforts on creating and advancing new medications for diverse health issues across both the United States and China. The firm currently offers Quetiapine XR, a treatment for Schizophrenia, as well as Dexlansoprazole DR capsules. Beyond its existing portfolio, Handa is actively cultivating a robust pipeline of therapies. This includes their cutting-edge ONCORE drug delivery platform, engineered to boost patient adherence and improve the safety of tyrosine kinase inhibitor oncology drugs. Other significant projects encompass a 505(b)(2)NDA therapeutic agent, Tascenso ODT for managing multiple sclerosis, and the oncology candidates HND-033 and HND-027. Furthermore, the company's development initiatives feature HND-004, designed for diabetic patients; HND-032, intended to aid in smoking cessation; and HND-026, a gastrointestinal medication. Founded in 2014, Handa Pharmaceuticals, Inc. has its main corporate headquarters situated in Tainan City, Taiwan.
주가
$2.95
시가총액
$491.95M
변동 (1일)
9.94%
변동 (1년)
8.06%
국가
TW
거래 Handa Pharmaceuticals, Inc. (6620)

카테고리

Handa Pharmaceuticals, Inc. (6620)의 주가 이력
최고 종가: $2.50 (2026-08-01 기준)

최저 종가: $3.07 (2016-12-01 기준)
Handa Pharmaceuticals, Inc.의 주가 이력 (2016 ~ 2026)
연간 주가 성과
연도 성과
2026 (TTM) -6.68%
2025 76.45%
2024 -69.59%
2023 78.09%
2022 89.09%
2021 96.39%
2020 3.11%
2019 -3.91%
2018 -21.54%
2017 -62.75%
2016 0.00%
유사 기업 또는 경쟁사의 주가
회사 주가 변동률 1년% 국가
$171.67 -
DE
$164.88 30.29%
DE
$37.61 25.11%
JP
$21.90 21.12%
IN
$218.36 25.22%
CH